TRINITY BIOTECH PLC-SPON ADR (TRIB)       1.21  +0.01 (+0.83%)

Trinity Biotech Announces The Appointment of Aris Kekedjian As Chairman and CEO

DUBLIN, Ireland, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...

Trinity Biotech Announces Results of AGM

DUBLIN, Ireland, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time for another breakdown of the biggest pre-market stock movers and the news that's moving those shares on Wednesday!

Trinity Biotech Announces Quarter 1 2022 Financial Results

DUBLIN, Ireland, June 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...

Trinity Biotech plc to Announce First Quarter Fiscal Year 2022 Financial Results

Conference Call Scheduled for June 30, 2022 at 11:00 am EASTERN...

Trinity Biotech Announces CE Mark of its 10-Minute Covid-19 Antigen Test

DUBLIN, Ireland, May 20, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has achieved a CE Mark for its 10-minute Covid-19 antigen test. This...

Trinity Biotech Announces the Successful Closing of its Strategic Investment and Partnership With The MiCo Group of South Korea

DUBLIN, Ireland, May 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the...

Trinity Biotech Announces Quarter 4 and Fiscal Year 2021 Financial Results

DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...

Trinity Biotech Announces A $45 Million Strategic Investment And Partnership With The MiCo Group of South Korea

DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading global diagnostic company (“Trinity Biotech” or the...

Trinity Biotech Announces the World Health Organisation Approval Of TrinScreen™ HIV

DUBLIN, Ireland, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has received approval for its new HIV screening product,...

Trinity Biotech Announces The Successful Closing of its Debt Refinancing

DUBLIN, Ireland, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...

Trinity Biotech Announces That Its Shareholders Have Approved All of the Four Resolutions That Were the Subject of the EGM Held on January 25, 2022

DUBLIN, Ireland, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...

Trinity Biotech Announces Q3 2021 Results, the Entry Into a $81,250,000 Loan Facility to Refinance the Company’s Exchangeable Senior Notes and Agreements To Repurchase Outstanding Exchangeable Senior Notes

DUBLIN, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products...

Sidoti - Fall Virtual Small Cap Investor Conference

Presentation Times and Weblinks Released for Over 130 Presenting Companies Wednesday and Thursday, September 22 - 23, 2021 NEW YORK, NY / ACCESSWIRE / September 21, 2021 / Sidoti & Company, LLC proudly releases the presentation schedule, with weblink click-throughs, for its Sidoti Fall Virtual Small Cap Investor Conference, to be held on Wednesday, September 22, 2021, and Thursday, September 23, 2021. Virtual Agenda - Wednesday, September

Trinity Biotech Announces Results for Q2, 2021

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2021 Financial Results

Conference Call Scheduled for September 9, 2021 at 11:00 am EASTERN